Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2018 · 10-Q
Revenue$163.97M$163.97M+13.8% vs Q3 2017 Net Income$19.74M$19.74M−11.0% vs Q3 2017 EPS Diluted$0.52$0.52−11.9% vs Q3 2017 Gross Profit$110,261,000+14.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$21,650,000−13.5% Free Cash Flowderived$18,142,000−13.6% Margins · derivedGross margin67.2%+0.1 pt vs Q3 2017
Operating margin26.3%+3.0 pt vs Q3 2017
Net margin12.0%−3.4 pt vs Q3 2017
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end